Ahmed A Holiel | Dentistry | Research Excellence Award

Assist. Prof. Dr. Ahmed A Holiel | Dentistry | Research Excellence Award

Alexandria University, Beirut Arab University | Egypt

Assist. Prof. Dr. Ahmed A. Holiel is an accomplished academic and clinician specializing in Restorative and Esthetic Dentistry, with a core research focus on biomaterials, pulp regeneration, digital dentistry, and adhesive restorative systems. He earned his Bachelor’s degree with honors from the Faculty of Dentistry, Alexandria University, followed by a Master’s and Ph.D. in Restorative & Esthetic Dentistry from the same institution. Notably, he became the first researcher at Alexandria University’s Faculty of Dentistry to be exempted from Ph.D. thesis defense after publishing two articles in top-tier ISI journals. Dr. Holiel has progressed through a solid academic career pathway, beginning as a Demonstrator and later assuming roles as Assistant Lecturer and Lecturer at Alexandria University. He currently serves as an Assistant Professor of Restorative & Esthetic Dentistry at Beirut Arab University, Lebanon. He has also contributed internationally as a visiting lecturer at multiple institutions, including the Arab Academy for Science, Technology & Maritime Transport. His contributions to research are significant, with numerous peer-reviewed publications in well-recognized journals covering tissue engineering, biomimetic materials, laser dentistry, pulp regeneration, and emerging technologies in dental science. His work includes multiple clinical trials, in vitro studies, systematic reviews, meta-analyses, and innovation-driven translational research. He also serves as a peer reviewer for leading scholarly journals and acts as Guest and Lead Editor for notable international journals, demonstrating his expertise and academic leadership. Dr. Holiel’s teaching portfolio includes undergraduate, postgraduate, and international credit-hour programs, with roles as course director and coordinator in various operative and esthetic dentistry modules. His clinical experience extends to digital workflows, CAD/CAM systems, smile design, and laser-assisted restorative procedures. A recipient of several distinctions, including the Egyptian Hatton Award and multiple institutional recognitions, Dr. Holiel is an active member of global professional bodies such as the International Association for Dental Research (IADR) and the Tissue Engineering and Regenerative Medicine Society.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Grawish, M. E., Grawish, L. M., Grawish, H. M., Grawish, M. M., Holiel, A. A., Sultan, N., … (2022). Demineralized dentin matrix for dental and alveolar bone tissues regeneration: An innovative scope review. Tissue Engineering and Regenerative Medicine, 19(4), 687–701.

Holiel, A. A., Mahmoud, E. M., Abdel-Fattah, W. M., & Kawana, K. Y. (2021). Histological evaluation of the regenerative potential of a novel treated dentin matrix hydrogel in direct pulp capping. Clinical Oral Investigations, 25(4), 2101–2112.

Holiel, A. A., Mahmoud, E. M., & Abdel-Fattah, W. M. (2021). Tomographic evaluation of direct pulp capping using a novel injectable treated dentin matrix hydrogel: A 2-year randomized controlled clinical trial. Clinical Oral Investigations, 25(7), 4621–4634.

Morsy, N., & Holiel, A. A. (2023). Color difference for shade determination with visual and instrumental methods: A systematic review and meta-analysis. Systematic Reviews, 12(1), 95.

Abbassy, K. M., Elmahy, W. A., & Holiel, A. A. (2023). Evaluation of the proximal contact tightness in class II resin composite restorations using different contact forming instruments: A 1-year randomized controlled clinical trial. BMC Oral Health, 23(1), 729.

Bo Wan | Medicine and Dentistry | Best Researcher Award

Dr. Bo Wan | Medicine and Dentistry | Best Researcher Award

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China

Dr. Bo Wan is an emerging clinician–scientist in the field of ophthalmology, recognized for his strong commitment to advancing clinical practice and research related to myopia, cataract, and retinal disorders. With several years of experience as an ophthalmologist in a leading medical institution, he has developed extensive competence in the diagnosis, management, and surgical treatment of common and complex ocular diseases. His clinical work is characterized by precision, rigorous reasoning, and patient-centered decision-making, contributing to improved visual outcomes and enhanced quality of life for diverse patient populations. In parallel with his clinical responsibilities, Dr. Wan has maintained an active engagement in academic research, focusing on evidence-based approaches to ophthalmic disorders and exploring strategies for disease prevention and early intervention. He has authored 2 scholarly documents, which together have received 19 citations and an h-index of 1, reflecting the early but growing influence of his research contributions. His work demonstrates a consistent interest in the integration of clinical insights with scientific inquiry, and he has collaborated with colleagues across medical and academic settings to advance shared research goals. These collaborations have supported the development of multidisciplinary perspectives that enrich both clinical practice and investigative rigor. Dr. Wan’s scholarly activities reflect a broader commitment to public health and societal benefit. By contributing to improved diagnostic accuracy and more effective therapeutic pathways in ophthalmology, his work supports long-term visual health and addresses the rising global challenges of myopia and age-related ocular diseases. He is dedicated to continuous professional development and intends to expand his research output, strengthen international collaborations, and contribute to high-impact studies that can influence global ophthalmic guidelines and clinical standards. With a strong foundation in clinical practice, disciplined research habits, and a clear vision for future growth, Dr. Bo Wan is well positioned to make meaningful and sustained contributions to ophthalmic science and global eye health.

Profile: Scopus

Featured Publications

  1. (2024). Parallel comparison of ocular metrics in non-human primates with high myopia by LS900, ultrasonography and MRI-based 3D reconstruction. Experimental Eye Research.

 

Ricardo Osorio | Medicine and Dentistry | Best Researcher Award

Dr. Ricardo Osorio | Medicine and Dentistry | Best Researcher Award

NYU Grossman School of Medicine, United States

Dr. Ricardo Osorio is a distinguished neuropsychiatrist and researcher specializing in the intersection of sleep, aging, and neurodegenerative disorders, particularly Alzheimer’s disease. He earned his M.D. from Universidad Autónoma de Madrid (Spain) in 2001, followed by multiple master’s degrees in Psychotherapy, Neuroscience, and Neuropsychology from Universidad Comillas and Universidad Complutense, Madrid, with a focus on executive function and cognitive aging. His clinical training includes residencies in psychiatry at 12 de Octubre Hospital, Madrid, internships in neurology at McGill University, Montreal, and neuropsychiatry at the Institute of Neurology, London, as well as postdoctoral neuroscience training at NYU Langone Health. Dr. Osorio’s professional career encompasses roles as attending psychiatrist in several Spanish hospitals, research scientist at Alzheimer’s Project Research Unit (CIEN Foundation) in Madrid, and progressive academic appointments at NYU School of Medicine and the Healthy Brain Aging and Sleep Center, where he is now a tenured associate professor. His research interests focus on sleep disorders as risk factors for neurodegeneration, slow-wave sleep and sleep spindle physiology, memory consolidation, and advanced neuroimaging techniques including PET imaging of glucose metabolism, amyloid, and tau in normal aging, cognitive decline, and Alzheimer’s disease. He possesses expertise in clinical psychiatry, cognitive assessment, neuroimaging analysis, sleep research methodologies, and interdisciplinary translational research. Dr. Osorio has received numerous awards and honors, including international fellowships, the Spanish National Psychiatry Residents Research Award, the Anne Elizabeth Suratt Young Investigator Award, and departmental mentorship recognitions. He has authored 130 publications, accumulated 9,893 citations, and holds an h-index of 44, reflecting his impactful contributions to science and clinical practice. Dr. Osorio’s work bridges neuroscience and clinical application, advancing understanding of cognitive aging, informing early detection strategies for Alzheimer’s disease, and contributing to the development of interventions that benefit patients and society at large, marking him as a leading figure in neuropsychiatric research and aging studies.

Profiles: Scopus | ORCID

Featured Publications

  1. Bernard, M. A., Boutajangout, A., Debure, L., Ahmed, W., Briggs, A. Q., Boza-Calvo, C., Vedvyas, A., Marsh, K., Bubu, O. M., Osorio, R. S., et al. (2024, July 10). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Preprint.

  2. Iosifescu, D. V., Song, X., Gersten, M. B., Adib, A., Cho, Y., Collins, K. M., Yates, K. F., Hurtado-Puerto, A. M., McEachern, K. M., Osorio, R. S., et al. (2023, July 13). Protocol report on the transcranial photobiomodulation for Alzheimer’s disease (TRAP-AD) study. Healthcare, 11(14), 2017.

  3. Parasoglou, P., Osorio, R. S., Khegai, O., Kovbasyuk, Z., Miller, M., Ho, A., Dehkharghani, S., Wisniewski, T., Convit, A., Mosconi, L., et al. (2022, December). Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease. Neuroimage: Reports, 2, 100121.

  4. Lal, C., Ayappa, I., Ayas, N., Beaudin, A. E., Hoyos, C., Kushida, C. A., Kaminska, M., Mullins, A., Naismith, S. L., Osorio, R. S., et al. (2022, August). The link between obstructive sleep apnea and neurocognitive impairment: An official American Thoracic Society workshop report. Annals of the American Thoracic Society, 19(8), 1250–1267.

  5. Teipel, S., Bruno, D., Plaska, C. R., Heslegrave, A., Ramos-Cejudo, J., Osorio, R. S., Zetterberg, H., Blennow, K., & Pomara, N. (2021, October). Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder. Journal of Affective Disorders, 295, 1017–1025.

Dr. Ricardo Osorio’s work advances the understanding of sleep and neurodegenerative disorders, particularly Alzheimer’s disease, by identifying early risk factors and therapeutic targets. His research bridges neuroscience and clinical practice, improving strategies for diagnosis, prevention, and intervention, thereby benefiting patients, healthcare systems, and society globally.

HYO-SANG PARK | Dentistry | Excellence in Research Award

Prof. HYO-SANG PARK | Dentistry | Excellence in Research Award

Department of Orthodontics, Kyungpook National Univsersity, South Korea

Prof. Hyo-Sang Park, DDS, MSD, Ph.D., is a distinguished scholar, clinician, and global leader in orthodontics, widely recognized for pioneering orthodontic microimplants that have revolutionized treatment protocols worldwide. He completed his Doctor of Dental Surgery (DDS) at Kyungpook National University in Daegu, Korea, followed by specialist orthodontic training and authorization at Kyungpook National University Hospital. He earned a Master of Science in Orthodontics and later obtained his Ph.D. in Oral Biology and Orthodontics from Kyungpook National University, reflecting a solid academic foundation. Professionally, he has served as a full-time instructor, assistant professor, and associate professor at Keimyung University Medical College before becoming Professor and Chair of the Department of Orthodontics at Kyungpook National University, while also enriching his international exposure as a Visiting Associate Professor at the University of Oklahoma, USA. His research interests include the development of orthodontic microimplants, microimplant-assisted orthodontic treatment, clear aligner-microimplant combined treatment, and orthognathic surgery. With expertise spanning biomechanics, surgical orthodontics, device design, and clinical applications, his research skills have resulted in over 114 indexed publications, 4,303 citations, and an h-index of 33, alongside multiple patents for orthodontic anchorage systems and innovative devices. His books and monographs, translated into Korean, English, Japanese, Chinese, Spanish, and Portuguese, further highlight his international influence, and his more than 200 lectures, 300 training courses, and global presentations underscore his role as a thought leader and educator. Prof. Park has received widespread recognition for his contributions, including leadership in academic societies, authorship of standard orthodontic textbooks, and patents that bridge clinical innovation with patient care. In conclusion, Prof. Hyo-Sang Park’s career reflects an exceptional blend of academic excellence, pioneering research, international collaboration, and mentorship, making him highly deserving of global recognition for his transformative contributions to orthodontics and his ongoing potential to advance the field through innovation, leadership, and education.

Profile: Scopus | ORCID | Google Scholar

Featured Publication

Park, H. S., Jeong, S. H., & Kwon, O. W. (2006). Factors affecting the clinical success of screw implants used as orthodontic anchorage. American Journal of Orthodontics and Dentofacial Orthopedics, 130(1), 18–25.  — Cited 984

Park, H. S. (2001). MIA (Micro-Implant Anchorage) for Class I bialveolar protrusion. Journal of Clinical Orthodontics, 35(7), 417–422. — Cited 803

Kyung, H. M., Park, H. S., Bae, S. M., & Jae-Hyun, S. (2003). Overview: Development of orthodontic micro-implants for intraoral anchorage. Journal of Clinical Orthodontics, 37(6), 321–328. — Cited 718

Bae, S., Park, H. S., Kyung, H. M., Kwon, O. W., & Sung, J. H. (2002). Clinical application of micro-implant anchorage. Journal of Clinical Orthodontics, 36(5), 298–302. — Cited 583

Lee, M. H., Kwon, T. G., Park, H. S., Wozney, J. M., & Ryoo, H. M. (2003). BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communications, 309(3), 689–694. Cited 561

Maria Kourti | Medicine and Dentistry | Best Researcher Award

Prof. Maria Kourti | Medicine and Dentistry | Best Researcher Award

Aristotle University of Thessaloniki | Greece

Prof. Maria Kourti is a distinguished academic and medical professional specializing in Pediatrics with a particular focus on Pediatric Hematology, Oncology, and Infectious Diseases. She currently serves as an Assistant Professor at Aristotle University of Thessaloniki, where she has been deeply involved in both teaching and research. Her career spans over two decades of excellence in clinical practice, scientific research, and international collaborations, with significant contributions to the understanding of childhood leukemia, drug resistance mechanisms, and pediatric infectious diseases. She has authored 73 publications indexed in PubMed, holds an h-index of 16, and has received over 1,000 citations, making her a recognized figure in her field. Prof. Kourti has combined clinical expertise with cutting-edge molecular and proteomic research, actively leading and participating in international multicenter studies and clinical trials. She is also extensively engaged in professional societies at the European and global levels, serving as a board member and committee leader in organizations dedicated to pediatric health. Alongside her academic achievements, she has contributed to medical education, mentorship, and health promotion initiatives, underlining her holistic approach to advancing both science and society. Her distinguished record makes her a highly respected leader in pediatric research and medicine.

Professional Profile

Scopus | ORCID 

Education

Prof. Maria Kourti pursued her entire academic journey at the Aristotle University of Thessaloniki, Greece, one of the most prestigious institutions in the country. She obtained her Medical Degree, laying the foundation for her career in pediatrics. With a strong interest in scientific research, she further advanced her education by earning a Master of Science (MSc) in Medical Research Technology, where she developed early expertise in biomedical investigations. Her passion for oncology and molecular medicine culminated in her Ph.D, with her thesis focused on the “Study of expression of multi-drug resistance genes in pediatric leukemia,” a topic that remains central to her research today. Her commitment to academic and clinical growth did not stop there, as she pursued advanced medical specialization, becoming Board Certified as a Specialist Pediatrician and later recognized as a Pediatric Infectious Disease Specialist. In the same year, she also completed a Post-Doctoral Fellowship in Proteomics in Childhood Leukemia, marking her continued dedication to translational research. This progression highlights her unique integration of medicine and science, equipping her with the academic depth and clinical expertise to make pioneering contributions in pediatric hematology, oncology, and infectious diseases.

Professional Experience

Prof. Maria Kourti has held several critical roles in clinical practice and academia, reflecting her dual expertise as a physician and researcher. she served as an Attending Physician in the Pediatric Oncology Department at Hippokration General Hospital, where she gained extensive clinical experience in treating children with hematological malignancies and solid tumors. Her expertise further deepened during her Pediatric Infectious Disease Fellowship at Aristotle University of Thessaloniki, based at Hippokration General Hospital. she worked as an Attending Physician in the 3rd Department of Pediatrics at Aristotle University, responsible for managing the Pediatric Hematology Unit, demonstrating her leadership in both patient care and academic responsibilities. she was appointed Assistant Professor of Pediatrics–Pediatric Hematology and Oncology at Aristotle University of Thessaloniki, where she continues to combine clinical duties with teaching and high-level research. Her responsibilities extend beyond the university, as she actively participates in national and international research programs, leading initiatives on childhood cancer, supportive care, and clinical trials. Through these roles, Prof. Kourti has developed a reputation for clinical excellence, academic leadership, and research innovation, making her a central figure in pediatric hematology and oncology in Greece and abroad.

Research Interests

Prof. Kourti’s research interests span the intersection of molecular biology, pediatric oncology, and infectious diseases, with a strong emphasis on improving treatment outcomes for children with cancer. Her doctoral and postdoctoral work centered on the molecular mechanisms of drug resistance in childhood leukemia, specifically the expression of multi-drug resistance genes and the application of proteomics to understand disease progression and treatment response. She has also been deeply engaged in genetic polymorphism studies, particularly in metabolic enzymes of carcinogenic substances in patients with acute leukemias and myelodysplastic syndromes. In addition to her oncology work, she has pursued significant research in pediatric infectious diseases, coordinating national efforts for the Greek Supportive Care Group and contributing to clinical research on antifungal therapies and novel antimicrobial strategies. Her interests also extend to large-scale clinical collaborations, where she has been both principal and sub-investigator in 15 multinational clinical trials addressing treatments for pediatric cancers and infections. This breadth of research demonstrates her commitment to translational medicine, bridging laboratory research with clinical applications. Her interests align with global health priorities, focusing on improving survival, reducing treatment toxicity, and enhancing supportive care in children with cancer.

Research Skills

Prof. Kourti possesses a strong foundation in molecular biology and clinical research methodologies, supported by advanced training and decades of practical application. Her technical expertise includes DNA and RNA extraction from blood and bone marrow samples, agarose gel electrophoresis, PCR, and RT-PCR, enabling her to investigate genetic and proteomic markers in pediatric leukemia. She has extensive experience with clinical trial design and implementation, having served as both a principal investigator and sub-investigator in numerous international studies, particularly within the SIOPE and SIOPEN networks. Her skills also extend to multidisciplinary collaboration, coordinating research teams across clinical and laboratory settings. In addition, Prof. Kourti has developed editorial and peer-review skills through her role as Guest Editor of special issues in international journals such as the Journal of Fungi and Diagnostics and as a reviewer for more than 10 medical journals. She also demonstrates expertise in data interpretation, publication writing, and conference presentation, with over 100 oral and poster presentations at national and international congresses. Her combined clinical and laboratory research skills, along with her organizational and editorial experience, make her a versatile and influential contributor to pediatric oncology and infectious disease research worldwide.

Awards and Honors

Throughout her career, Prof. Maria Kourti has received numerous awards and honors recognizing her excellence in research, teaching, and clinical practice. She has earned 10 major distinctions, including 3 scholarships from the National Scholarship Foundation (IKY), awarded for her academic performance and research potential. In addition, she has received 3 educational grants supporting her clinical and research training, as well as 6 first prizes for oral and poster presentations at both national and international medical congresses. These awards highlight not only her dedication to scientific inquiry but also her ability to effectively communicate her findings to diverse audiences. Beyond individual recognition, her leadership roles within professional societies such as the Hellenic Society for Social Pediatrics and Health Promotion, the National Pediatric Hematology and Oncology Society, and participation in European cooperative groups (SIOPE, ESPID, EXPeRT, ESCMID) further demonstrate the esteem in which she is held by the medical and scientific community. She has also contributed as a committee member for sustainability at ESPID, reflecting her commitment to long-term scientific advancement and ethical research practices. These honors collectively underscore her outstanding achievements and her influential role in pediatric medicine and research.

Publication Top Notes

  • Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO) — 2025

  • A Global Analysis of Cases of Mucormycosis Recorded in the ECMM / ISHAM Zygomyco.net Registry from 2009 to 2022 — 2025

  • Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Research Network — 2025 — 3 citations

  • Addressing infectious challenges in pediatric cancer and hematopoietic cell transplantation: insights from the Umbrella Working Group — 2025

  • Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients — 2025

  • Planetary Health: What You Need to Know as a Pediatric Infectious Diseases Doctor — 2025

  • Successful Treatment of Disseminated Fusariosis in a 15-Month-old Boy With Refractory Acute Lymphoblastic Leukemia Using High-dose Voriconazole — 2024 — 1 citation

  • Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps — 2025

Conclusion

Prof. Maria Kourti exemplifies the qualities of a leading physician-scientist, with a career that integrates clinical expertise, innovative research, and academic leadership. Her groundbreaking work in childhood leukemia, infectious diseases, and pediatric oncology has advanced both scientific knowledge and clinical practice, directly impacting patient outcomes. With more than 73 peer-reviewed publications, extensive participation in international clinical trials, and leadership in national and European research groups, she has established herself as a key figure in the global pediatric research community. Her commitment to mentoring young scientists, active involvement in health promotion initiatives, and editorial contributions further enhance her academic profile. Looking ahead, Prof. Kourti is well-positioned to expand her research into global collaborations, increase her presence in high-impact journals, and take on greater leadership roles in shaping international pediatric oncology policies. Her career trajectory reflects not only past accomplishments but also significant potential for future contributions to medicine, making her a highly deserving candidate for continued recognition. In summary, Prof. Kourti’s lifelong dedication to advancing pediatric care and medical science positions her as an outstanding role model and leader in the field.

Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Mr. Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Hawassa University, Ethiopia

Dr. Agete Tadewos Hirigo is an Assistant Professor at Hawassa University in Ethiopia, specializing in clinical chemistry and medical laboratory sciences. With a robust academic background and extensive research experience, he has significantly contributed to the fields of metabolic disorders, infectious diseases, and clinical diagnostics. Dr. Hirigo has authored over 40 peer-reviewed publications, reflecting his commitment to advancing medical science and improving healthcare outcomes in Ethiopia and beyond.

Professional Profile

Education

Dr. Hirigo’s academic journey began with a Diploma in Medical Laboratory Technology from Addis Ababa University in 2000. He then earned a BSc in Medical Laboratory Technology Sciences from Hawassa University in 2009. In 2012, he completed his MSc in Clinical Laboratory Sciences (Clinical Chemistry) at the University of Gondar. Currently, he is pursuing a PhD in Clinical Nutrition at Addis Ababa University, demonstrating his dedication to continuous learning and specialization in his field.

Professional Experience

Dr. Hirigo’s professional career spans over two decades. He started as a Senior Lab Technologist at Hawassa University Comprehensive Specialized Hospital from 2009 to 2011. He then served as an Expert Clinical Chemist from 2012 to 2015. From 2015 to 2019, he was a Lecturer at the School of Medical Laboratory Sciences, Hawassa University. Since July 2019, he has been serving as an Assistant Professor, where he is involved in lecturing, research, student supervision, and quality assurance in clinical chemistry laboratories.

Research Interests

Dr. Hirigo’s research interests are diverse and impactful. He focuses on metabolic disorders such as dyslipidemia and metabolic syndrome, particularly among HIV-infected and psychiatric patients. His work also encompasses the study of antiretroviral therapy effects, infectious diseases like hepatitis B and C, and public health issues such as hand hygiene practices among schoolchildren. His research aims to address critical health challenges in Ethiopia, contributing to evidence-based interventions and policies.

Research Skills

Dr. Hirigo possesses a comprehensive skill set in clinical laboratory sciences. His expertise includes laboratory diagnostics, clinical chemistry, and the use of statistical tools like SPSS for data analysis. He is proficient in designing and conducting cross-sectional and cohort studies, laboratory quality assurance, and instrument maintenance. His skills are instrumental in both academic research and practical laboratory settings, ensuring high standards of laboratory services and research outputs.

Awards and Honors

While specific awards and honors are not detailed in the available information, Dr. Hirigo’s extensive publication record and academic positions indicate recognition in his field. His involvement in significant research projects and collaborations with other institutions reflect his esteemed status in the academic and medical communities.

Conclusion

Dr. Agete Tadewos Hirigo exemplifies the qualities of a dedicated researcher and educator. His extensive experience, diverse research interests, and commitment to improving healthcare through science make him a valuable asset to the medical community. His work not only advances scientific knowledge but also has practical implications for public health in Ethiopia. Dr. Hirigo’s ongoing contributions continue to inspire and influence the field of clinical laboratory sciences.

Publications Top Notes

📘 1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Authors: SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, …
Journal: New England Journal of Medicine, 387(11), 978–988 (2022)
Citations: 200
🔬 Major randomized trial comparing rivaroxaban and vitamin K antagonists in RHD-AF.

📘 2. Hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients at Hawassa University
Authors: SB Woyesa, AT Hirigo, TB Wube
Journal: BMC Endocrine Disorders (2017)
Citations: 96
🧪 Correlation study of uric acid levels and metabolic syndrome in diabetic patients.

📘 3. Prevalence of Dyslipidemia Among HIV-Infected Patients Using First-Line HAART
Authors: A Tadewos, Z Addis, H Ambachew, S Banerjee
Journal: AIDS Research and Therapy (2012)
Citations: 91
🩺 Comparative cross-sectional analysis in Southern Ethiopia.

📘 4. Burden of Metabolic Syndrome Among HIV-Infected Patients in Southern Ethiopia
Authors: DY Tesfaye, S Kinde, G Medhin, YC Megerssa, A Tadewos, E Tadesse, …
Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8(2), 102–107 (2014)
Citations: 84
🧬 Assessment of metabolic complications among PLHIV on ART.

📘 5. Hepatitis B Virus Among Pregnant Women in Yirgalem Hospital, Ethiopia
Authors: A Amsalu, G Ferede, S Eshetie, A Tadewos, D Assegu
Journal: Journal of Pregnancy (2018), Article ID: 8435910
Citations: 78
👶 Implication of HBV screening for preventing mother-to-child transmission.

📘 6. The INVICTUS Rheumatic Heart Disease Research Program
Authors: G Karthikeyan, SJ Connolly, M Ntsekhe, A Benz, S Rangarajan, G Lewis, …
Journal: American Heart Journal, 225, 69–77 (2020)
Citations: 52
🫀 Study design for comparing rivaroxaban vs. VKA in RHD.

📘 7. Gender Influence in Metabolic Syndrome Among PLHIV on ART
Authors: AT Hirigo, DY Tesfaye
Journal: BMC Research Notes (2016)
Citations: 45
📊 Exploration of sex-based differences in ART-related metabolic issues.

📘 8. Length of Stay in Emergency Departments in Southern Ethiopia
Authors: GH Alemu, KG Negari, KM Rodamo, AT Hirigo
Journal: BMC Research Notes (2019)
Citations: 43
🏥 Study of variables influencing emergency department stay duration.

📘 9. Hand Washing Practices Among Primary Schoolchildren in Yirgalem
Authors: D Eshetu, T Kifle, AT Hirigo
Journal: Journal of Multidisciplinary Healthcare (2020), 759–768
Citations: 36
🧼 KAP study on hygiene practices among schoolchildren.

📘 10. Coinfections with Hepatitis B, C, and Syphilis Among HIV Patients
Authors: T Shimelis, Y Tassachew, A Tadewos, MW Hordofa, A Amsalu, …
Journal: HIV/AIDS – Research and Palliative Care
Citations: 33
⚕️ Cross-sectional data on coinfection rates in PLHIV.

 

Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Assist. Prof. Dr. Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Consultant Nephrologist from Imam Abdulrahman Bin Faisal, Saudi Arabia

Dr. Mohamed Ahmed Nasreldin is an American consultant internist and nephrologist currently serving as Assistant Professor at King Fahad Hospital of the University (KFHU), Dammam, Saudi Arabia. With over 16 years of clinical experience, he has demonstrated exceptional competence in both internal medicine and nephrology, managing complex cases with compassion, precision, and interdisciplinary collaboration. Dr. Nasreldin holds a rich academic background complemented by international qualifications and fellowships, including the prestigious Fellow of the American Society of Nephrology (FASN). His work spans clinical care, teaching, and research, particularly in dialysis, kidney transplantation, and interventional nephrology. A committed educator, he has contributed significantly to medical education by tutoring nephrology fellows and mentoring residents and medical students. His fluency in Arabic, English, and Russian enhances his ability to connect across cultures and deliver impactful education and care. Dr. Nasreldin has received several awards and certificates of appreciation for his excellence in research presentations, academic contributions, and leadership in clinical practice. With a strong foundation in research and clinical trials, he has authored multiple peer-reviewed publications and continues to contribute to national and international nephrology forums. His career reflects a balanced dedication to patient care, clinical innovation, and academic leadership.

Professional Profile

Education

Dr. Mohamed Ahmed Nasreldin has pursued a comprehensive and international academic journey in medicine and nephrology. He holds a PhD in Clinical Nephrology (2016–2019) from UCN, USA, and a Clinical MD in Internal Medicine from Odessa State Medical University, Ukraine (2005–2009). He also earned an MBBS with honors in Medicine and Surgery from the same institution. His postgraduate education includes an MSc in Renal Medicine and a Postgraduate Diploma in Renal Medicine from the University of South Wales, UK. Dr. Nasreldin’s credentials also include the European Specialty Examination in Nephrology (ESENeph), jointly administered by the UEMS and the Royal College of Physicians, UK, along with a Fellowship from the American Society of Nephrology (FASN) awarded in 2019. His education is further supported by numerous certifications from globally recognized institutions, such as Johns Hopkins University (clinical research), the University of Leiden (kidney and pancreas transplantation), and the Royal College of Physicians, UK (renal medicine). In addition, he has completed specialized training in kidney pathology, gout management, and ADPKD treatment. This robust academic foundation not only underpins his clinical and research proficiency but also reflects his commitment to lifelong learning and evidence-based practice.

Professional Experience

With 16 years of experience in internal medicine and nephrology, Dr. Mohamed Nasreldin has established himself as a highly competent and dedicated clinician. He began his medical career with a residency program at Odessa State Medical University, where he gained extensive exposure to various subspecialties. Since 2009, he has been an integral part of the internal medicine department at King Fahad Hospital of the University (KFHU), Saudi Arabia. In this role, he manages both inpatient and outpatient care, including hemodialysis and peritoneal dialysis patients, and is actively involved in hospital consultations and on-call duties. Dr. Nasreldin’s clinical expertise covers a broad spectrum, from acute kidney injury and chronic kidney disease to renal transplantation and interventional nephrology. In addition to his clinical responsibilities, he plays a pivotal role in medical education and training. He tutors nephrology fellows, mentors residents, and delivers lectures to undergraduate and postgraduate students. His leadership in clinical care, education, and patient safety has been consistently recognized by peers and institutional authorities. Known for his problem-solving abilities under pressure, team collaboration, and organizational skills, Dr. Nasreldin continues to contribute significantly to both patient outcomes and the development of future nephrologists.

Research Interests

Dr. Mohamed Nasreldin’s research interests lie primarily in clinical nephrology, with a strong focus on dialysis modalities, renal transplantation, and interventional nephrology. He is particularly passionate about improving outcomes for patients on peritoneal dialysis and exploring patient-centered decision-making processes in renal care. His doctoral research examined the use of prophylactic antibiotics in end-stage renal disease (ESRD) patients undergoing colonoscopy while on automated peritoneal dialysis—a prospective randomized controlled trial that reflects his commitment to optimizing clinical protocols through evidence-based research. Dr. Nasreldin is also interested in transplant nephrology, including the management of acute and chronic allograft nephropathy, and the development of new catheter insertion techniques. His research extends to diabetes-related kidney disease, endothelial dysfunction in ischemic heart disease, and innovative strategies in nephrology education and practice. He has actively participated in clinical trials, presented findings at national and international conferences, and published research aimed at improving therapeutic outcomes in nephrology. As a mentor, he supervises clinical research for residents and fellows, fostering an academic environment that values inquiry and innovation. His dedication to research enhances his clinical practice, ensuring that patients benefit from the most current and effective medical interventions.

Research Skills

Dr. Nasreldin possesses a well-rounded set of research skills developed over more than a decade of conducting clinical investigations in internal medicine and nephrology. He is experienced in the design, monitoring, and execution of clinical trials, particularly randomized controlled studies that assess new interventions in renal care. His skills encompass the formulation of research hypotheses, patient recruitment and consent, data collection and analysis, and the interpretation of clinical findings for publication and presentation. Dr. Nasreldin is also proficient in guiding research as a supervisor and mentor, especially for nephrology fellows and internal medicine residents. His methodological strengths include statistical analysis, critical appraisal of the literature, and integration of research into clinical practice. Additionally, his ability to present research findings at scientific forums and publish in peer-reviewed journals underscores his communication and academic writing abilities. He is trained in research ethics and regulatory compliance, having completed a clinical research certificate from Johns Hopkins University. His involvement in various educational workshops and clinical symposiums enhances his collaborative research experience. These research skills have enabled him to contribute significantly to medical knowledge in nephrology, while also improving clinical decision-making and patient outcomes.

Awards and Honors

Dr. Mohamed Nasreldin has been recognized multiple times for his contributions to nephrology through awards and certificates of appreciation, reflecting both his clinical excellence and academic achievements. Notably, he received a Certificate of Appreciation at the First Gulf Peritoneal Dialysis Forum in Oman (2024) and won first place for poster presentation at the ISN-EMAN Update Congress in Nephrology, Dubai (2017). His oral presentation on acute kidney injury at the Saudi International Congress of Nephrology and Transplantation (2018) earned commendation, as did his role as a speaker at the International Conference of Diabetes and Its Complications in Baltimore (2017). He was honored by the nephrology division at King Fahad Hospital of the University for upholding high standards of care aligned with JCI requirements. Additionally, his participation in public awareness events, such as World Kidney Day, and academic initiatives like the 3rd Annual Research Day at King Saud University (2012), further illustrate his professional commitment. These accolades emphasize his role as a thought leader in nephrology, combining research, clinical practice, and public engagement. The consistent recognition from national and international platforms affirms Dr. Nasreldin’s impact on advancing kidney health and medical education.

Conclusion

Dr. Mohamed Ahmed Nasreldin stands out as a distinguished clinician, educator, and researcher in the field of nephrology, making him a strong candidate for the Excellence in Research Award. His extensive academic background, including a PhD in clinical nephrology and fellowship with the American Society of Nephrology, lays the foundation for his clinical acumen and research productivity. With over 16 years of experience, Dr. Nasreldin has shown exemplary commitment to improving patient outcomes, mentoring the next generation of physicians, and contributing to the scientific community. His research spans dialysis innovations, kidney transplantation, and interventional nephrology, all grounded in real-world clinical challenges. While his scholarly output could benefit from more high-impact journal publications and international collaborations, his existing contributions and active engagement in medical forums are noteworthy. Dr. Nasreldin’s work aligns closely with the criteria for the Excellence in Research Award—particularly through his original investigations, teaching impact, and patient-centered clinical innovations. His trajectory reflects a blend of practical application and academic inquiry, reinforcing his value to the nephrology community. Continued institutional support and broader research dissemination could further enhance his profile, making him not only a deserving recipient but also a future leader in academic nephrology.

Publications Top Notes

  1. An update on sickle cell nephropathy
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 25(2), 249–265
    Year: 2014
    Citations: 54

  2. The use of SGLT2 inhibitors in peritoneal dialysis patients: a shade of light on dapagliflozin
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, M.A. Nasreldin, A.M. Mohammed, …
    Journal: Archives of Nephrology and Urology, 5(1), 1–8
    Year: 2022
    Citations: 15

  3. Pregnancy in peritoneal dialysis and an infant with a ventricular septal defect
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 26(1), 111–114
    Year: 2015
    Citations: 8

  4. A nephrologist dream of peritoneal dialysis catheter with zero migration: a multicenter prospective study
    Authors: A.K. Al‐Hwiesh, I.S. Abdul‐Rahman, J.C. Divino‐Filho, M.A. Nasreldin, …
    Journal: Therapeutic Apheresis and Dialysis, 28(1), 89–95
    Year: 2024
    Citations: 5

  5. A novel three cuff peritoneal dialysis catheter with low entry technique: three years single center experience
    Authors: A. Al-Hwiesh, I. Abdul-Rahman, N. Al-Audah, A. Noor, M. Nasreldin
    Journal: Urol Nephrol Open Access J, 4(5), 150–156
    Year: 2017
    Citations: 5

  6. The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, A. Alshehri, A. Alhwiesh, M. Elnokeety, …
    Journal: BMC Nephrology, 23(1), 386
    Year: 2022
    Citations: 4

  7. Is percutaneous gastrostomy tube insertion contraindicated in adult peritoneal dialysis patients? A single-centre experience of three successful cases: it is time to revisit
    Authors: A. Alhwiesh, L. Alayoobi, H.A. Aljenaidi, K.M. Alshehabi, I. Abokaker Alghnimi, …
    Journal: The International Journal of Artificial Organs, 45(4), 438–441
    Year: 2022
    Citations: 2

  8. THE SAUDI PERITONEAL DIALYSIS CATHETER: MODIFIED CATHETER AND NEW TECHNIQUE: FAREWELL TO CATHETER MIGRATION
    Authors: A. Alhwiesh, M. Nasreldin
    Journal: Nephrology Dialysis Transplantation, 31
    Year: 2016
    Citations: 2

  9. The influence of increased peritoneal membrane surface area on dialysis adequacy
    Authors: A. Alhwiesh, S. Esam, I. Saeed, M. Ahmmed, F. Almohana
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 22(4), 717–722
    Year: 2011
    Citations: 2

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Dr. Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Corresponding Author from Hawassa university, Ethiopia

Dr. Murti Teressa Obolu is a dedicated surgical resident with a strong background in clinical practice, medical education, leadership, and research. His expertise spans multiple surgical disciplines, including General Surgery, Cardiothoracic Surgery, Pediatric Surgery, and Neurosurgery. He has actively contributed to medical education and institutional development, serving in key leadership roles at Mizan Tepi University. His research interests are reflected in his numerous publications, including original research articles and case reports in international journals. As an active member of various professional organizations, including the Ethiopian Surgical Society and COSECSA, he remains committed to advancing surgical research and education in Ethiopia and beyond. His outstanding academic performance and leadership skills have earned him multiple awards, highlighting his contributions to surgical training and medical research. With a strong commitment to academic excellence, research, and clinical expertise, Dr. Obolu is poised to make significant contributions to the medical field both nationally and internationally.

Professional Profile

Education

Dr. Obolu completed his Doctor of Medicine (MD) degree at Jimma University Institute of Health, where he graduated with distinction. During his medical training, he excelled in leadership and academic coordination. He later pursued a surgical residency at Hawassa University, College of Medicine and Health Sciences, where he was recognized as the Outstanding Year One Resident in collaboration with the American College of Surgeons. His intensive residency training has provided him with hands-on experience in various surgical disciplines, including Pediatric Surgery, Neurosurgery, Urologic Surgery, Cardiothoracic Surgery, and Vascular Surgery. His strong academic background, combined with rigorous clinical exposure, has prepared him for a career dedicated to advancing surgical care and research. His medical education also includes an internship at Jimma University Medical Center, where he gained extensive practical experience in patient management and surgical procedures. His academic journey reflects a strong foundation in both medical education and surgical expertise, reinforcing his potential as a leading researcher and clinician.

Professional Experience

Dr. Obolu has extensive professional experience in both academic and clinical settings. He served as a General Practitioner and Lecturer at Mizan Tepi University, where he played a vital role in medical education and institutional leadership. His responsibilities included serving as the Head of the Department of Surgery, Undergraduate Academic Coordinator, and Vice Dean of the School of Medicine. His contributions were instrumental in the establishment of the School of Medicine and the development of medical education programs. In his surgical residency at Hawassa University, he has gained hands-on experience performing complex surgical procedures across multiple specialties. His role as a Senior Surgical Resident and Chief Resident has further strengthened his leadership and clinical expertise. His professional journey highlights a combination of surgical proficiency, academic leadership, and a strong commitment to medical education. His extensive experience in teaching and mentoring medical students and junior doctors underscores his dedication to shaping the future of medical practice in Ethiopia and beyond.

Research Interest

Dr. Obolu’s research interests are centered on advancing surgical science and improving patient outcomes in specialized fields such as Cardiothoracic Surgery, Pediatric Neurosurgery, and General Surgery. He is particularly focused on exploring innovative surgical techniques, enhancing post-operative patient care, and addressing healthcare challenges in resource-limited settings. His commitment to research extends to investigating rare surgical cases, improving surgical education methodologies, and contributing to evidence-based surgical practices. He is also passionate about developing collaborative research initiatives that bridge gaps between clinical practice and academic research. Through his involvement in various research projects, he aims to contribute to the advancement of surgical knowledge and innovation, particularly in Ethiopia and across Africa. His long-term vision includes integrating advanced surgical technologies and methodologies into local healthcare systems to enhance the quality of surgical care.

Research Skills

Dr. Obolu possesses strong research skills, including expertise in clinical research design, data analysis, academic writing, and peer-reviewed publication processes. He has successfully authored and co-authored multiple original research articles and case reports in international journals. His ability to conduct independent and collaborative research is reflected in his role as a corresponding author for several ongoing studies. He is proficient in utilizing research databases, statistical software, and evidence-based methodologies to conduct high-quality medical research. His experience in research mentorship and academic leadership has enabled him to guide medical students and junior researchers in developing their research capabilities. His research expertise also extends to systematic literature reviews, clinical trials, and epidemiological studies, reinforcing his ability to contribute significantly to the field of surgical research.

Awards and Honors

Dr. Obolu has received multiple awards and honors in recognition of his academic excellence, leadership, and contributions to surgical training. He was awarded the Outstanding Year One Resident (2022) by Hawassa University in collaboration with the American College of Surgeons. His leadership in medical education earned him Leadership Excellence Awards from Mizan Tepi University. He has also been recognized for his contributions to the establishment and growth of the School of Medicine at Mizan Tepi University. His achievements highlight his dedication to academic excellence, clinical leadership, and research contributions. Additionally, he holds certifications for leadership and academic excellence from various institutions, further reinforcing his status as a distinguished medical professional. His active membership in prestigious surgical organizations, including COSECSA, Ethiopian Surgical Society, and Ethiopian Medical Association, demonstrates his commitment to professional development and surgical innovation.

Conclusion

Dr. Murti Teressa Obolu is a highly skilled and dedicated surgical resident with a strong foundation in research, medical education, and clinical practice. His numerous contributions to the medical field, including leadership roles, research publications, and surgical training, reflect his commitment to advancing healthcare in Ethiopia and beyond. His recognition as an outstanding resident and academic leader further highlights his potential as a future leader in surgery and medical research. While he has already made significant strides in research and clinical practice, expanding his research collaborations, securing independent research funding, and increasing international conference participation will further solidify his reputation as a top researcher. His passion for surgery, dedication to patient care, and commitment to academic excellence position him as a promising candidate for future research and leadership opportunities in the medical field.

Publications Top Notes

  1. Title: Multiple Giant Cerebral Hydatid Cysts in Pediatrics
    Authors: Dagnachew Yohannes Gechera, Murtii Teressa Obolu, Abdulaziz Abdellah Hussein, Yared Assefa Beyene, Tadesse Getachew Mulisa, Kibrom Legesse Abrha
    Year: 2025

  2. Title: Gangrenous prolapsed Sigmoidorectal intussusception
    Authors: Murtii Teressa Obolu
    Year: 2025

  3. Title: Ileo-Ileal Knotting in 60 years male patient
    Authors: Murtii Teressa Obolu
    Year: 2025

  4. Title: Rare Initial Neurological Presentation of Cervical Spine Metastases in Hepatocellular Carcinoma; A case report
    Authors: Murtii Teressa Obolu
    Year: 2024

  5. Title: Ileo-Ileal Knotting: A Case Report of a 60-Year-Old Male Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Tewodros Tadesse, Abdullahi Mohamed Muhumed, Murtii Teressa Obolu, Gediyon Getachew Gebo
    Year: 2024

  6. Title: Appendico-Ileal Knotting: A Case Report of 17-Year-Old Female Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Murtii Teressa, Tewodros Tadesse, Tadesse Getachow, Ermias Tadesse
    Year: 2024

  7. Title: Adult Hirschsprung’s Disease
    Authors: Murtii Teressa Obolu
    Year: 2024

  8. Title: SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia
    Authors: Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Eyob Tekalign, Teshale Worku, Gizachew Ayele, Yayeh Melaku, Abdulrezak Nuri, Murtii Teressa, Adinew Belay, et al.
    Year: 2023

  9. Title: Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: An institution-based cross-sectional study
    Authors: Mengistu Abayneh Sebsibe, Murtii Teressa, Sebsibe Tadesse
    Year: 2022

  10. Title: Acute respiratory infections (ARIs) and factors associated with their poor clinical outcome among children under-five years attending pediatric wards of public hospital in Southwest district of Ethiopia: A prospective observational cohort study
    Authors: Mengistu Abayneh Sebsibe, Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Molla Asnake, Murtii Teressa, Biruk Endalkachew, Milkiyas Toru
    Year: 2022

  11. Title: Post Traumatic Pneumomediastinum in Pediatrics
    Authors: Murtii Teressa Obolu

 

Sheng Guan | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Sheng Guan | Medicine and Dentistry | Best Researcher Award

Director Physician from THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY, China

Dr. Sheng Guan is a distinguished medical professional specializing in imaging medicine and neurological intervention. He serves as the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University and leads the Department of Neurological Intervention. Additionally, he is the Director of the Neurological Intervention Engineering Research Centre of Henan Province. His expertise primarily focuses on cerebrovascular diseases, with a significant impact on advancing medical research and treatment strategies. Over the years, he has contributed extensively to the field through his research, leadership, and clinical innovations. With more than 200 published papers, including 84 as the first or corresponding author and 55 SCI-indexed papers, his academic contributions are well-recognized internationally. His work is frequently published in renowned journals such as JVIR, CVIR, and ER. Dr. Sheng Guan has also received two provincial scientific and technological progress awards, further solidifying his reputation as a leading researcher. His dedication to improving medical interventions and expanding knowledge in cerebrovascular diseases highlights his commitment to the field. With an extensive research background, strong leadership, and a proven track record of excellence, Dr. Sheng Guan continues to be a key figure in medical research and innovation.

Professional Profile

Education

Dr. Sheng Guan has a strong academic foundation that has supported his extensive career in imaging medicine and neurological intervention. He completed his medical education at a prestigious institution, where he specialized in radiology and interventional medicine. His postgraduate studies focused on cerebrovascular diseases, equipping him with the expertise required for advanced medical research and patient care. Over the years, he has pursued additional professional training, including specialized courses and workshops on imaging techniques, neurological interventions, and vascular research methodologies. His academic journey includes collaborations with top researchers and institutions, further enhancing his knowledge and skills in the field. Dr. Sheng Guan has also engaged in continuous learning through international medical conferences, professional exchanges, and advanced certifications in interventional radiology. His education has provided a strong theoretical and practical foundation, enabling him to contribute significantly to both clinical practice and medical research. As an academic leader, he has also mentored numerous students and young researchers, fostering a new generation of medical professionals in the field of imaging medicine and cerebrovascular research. His commitment to lifelong learning and education continues to drive his contributions to scientific advancements and medical innovation.

Professional Experience

Dr. Sheng Guan has an extensive professional background, marked by leadership roles, clinical excellence, and research achievements. He is currently the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, where he leads a team of medical professionals in advancing imaging and neurological intervention techniques. Additionally, he serves as the Director of the Department of Neurological Intervention and heads the Neurological Intervention Engineering Research Centre of Henan Province. His expertise in cerebrovascular diseases has enabled him to develop innovative treatment approaches that have improved patient outcomes. Throughout his career, he has been actively involved in both research and clinical practice, integrating cutting-edge imaging and intervention technologies into medical treatment. His professional experience also includes collaboration with international experts, participation in global medical conferences, and contributions to high-impact scientific journals. Dr. Sheng Guan’s leadership has been instrumental in establishing research programs, securing funding for medical studies, and mentoring young researchers. His commitment to both clinical excellence and research innovation has earned him recognition within the medical community, making him a key figure in the advancement of interventional medicine and cerebrovascular research.

Research Interest

Dr. Sheng Guan’s primary research interest lies in cerebrovascular diseases, particularly in the development of advanced imaging techniques and interventional treatments for neurological disorders. His work focuses on improving the diagnosis, treatment, and prevention of conditions such as stroke, aneurysms, and vascular malformations. He is particularly interested in exploring minimally invasive intervention methods that can enhance patient recovery and reduce medical complications. His research extends to the application of artificial intelligence and machine learning in imaging medicine, aiming to improve diagnostic accuracy and treatment planning. Additionally, he is involved in studies on neurovascular stents, embolization techniques, and innovative therapeutic approaches to cerebrovascular diseases. Dr. Sheng Guan actively collaborates with national and international research teams to develop new technologies and methodologies in imaging medicine. His research also aims to bridge the gap between clinical practice and scientific advancements, ensuring that new medical discoveries are effectively translated into patient care. Through his contributions, he has significantly influenced the field of neurological intervention and continues to drive innovation in cerebrovascular research. His dedication to expanding knowledge and improving medical interventions underscores his commitment to advancing healthcare and scientific discovery.

Research Skills

Dr. Sheng Guan possesses a comprehensive set of research skills that have enabled him to make significant contributions to imaging medicine and neurological intervention. He is proficient in advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA), which are essential for diagnosing and treating cerebrovascular diseases. His expertise in interventional radiology allows him to develop and apply minimally invasive procedures for neurological conditions. Dr. Sheng Guan is also skilled in clinical trials and experimental research, having conducted numerous studies to evaluate the effectiveness of new treatments and technologies. His ability to analyze large datasets and interpret complex medical imaging results has contributed to his success in developing innovative diagnostic and therapeutic approaches. Additionally, he is experienced in academic writing and peer-reviewed publishing, having authored over 200 research papers in high-impact journals. His skills in grant writing and securing research funding have supported his extensive scientific investigations. Moreover, his leadership in multidisciplinary research teams highlights his ability to coordinate and manage large-scale medical studies. Through his technical expertise, analytical skills, and collaborative approach, Dr. Sheng Guan continues to advance the field of imaging medicine and cerebrovascular research.

Awards and Honors

Dr. Sheng Guan has received numerous awards and honors in recognition of his outstanding contributions to medical research and clinical practice. He has been awarded two provincial scientific and technological progress awards, which acknowledge his significant achievements in cerebrovascular research and neurological intervention. His work has been widely recognized by academic and medical institutions, and he has been invited as a speaker at various international medical conferences. Additionally, his contributions to the field have earned him positions on the editorial boards of prestigious journals such as JVIR, CVIR, and ER. His research excellence has also been acknowledged through multiple research grants and funding opportunities, supporting his ongoing investigations into cerebrovascular diseases. Dr. Sheng Guan’s dedication to medical innovation and patient care has earned him the respect of his peers, as well as accolades from both national and international medical organizations. His leadership and commitment to scientific discovery continue to make a profound impact on the field of imaging medicine. With a strong record of achievements and recognition, Dr. Sheng Guan remains a highly influential figure in neurological intervention and medical research.

Conclusion

Dr. Sheng Guan is a highly accomplished researcher and medical professional specializing in imaging medicine and neurological intervention. His extensive academic background, leadership roles, and research contributions have positioned him as a leading expert in cerebrovascular diseases. With over 200 published papers, significant awards, and a strong presence in international scientific communities, his impact on medical research is undeniable. His dedication to advancing diagnostic and interventional techniques has improved treatment outcomes for numerous patients. Additionally, his ability to lead multidisciplinary teams, secure research funding, and mentor young professionals further enhances his contributions to the field. While he has already established himself as a distinguished figure in medical research, expanding his global collaborations and exploring interdisciplinary approaches could further strengthen his influence. Dr. Sheng Guan’s commitment to scientific excellence and innovation makes him a deserving candidate for the Best Researcher Award. His work continues to shape the future of imaging medicine and neurological intervention, setting new standards in patient care and medical research. Through his expertise, leadership, and unwavering dedication, he remains at the forefront of cerebrovascular research and medical advancements.

Publication Top Notes

  • Title: Safety and efficacy of staged coiling followed by flow diverter in the treatment of ruptured intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; Z. Chen, Zhen; Y. Fu, Yu; S. Guan, Sheng
    Year: 2025

  • Title: Safety and efficacy of intrasaccular flow disruptor in intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; S. Guan, Sheng
    Year: 2025

  • Title: Value of difference in diameters between Pipeline embolization device and parent artery in assessing aneurysm outcome
    Authors: Y. Ma, Yajing; H. Zhang, Hang; C. Liu, Chao; S. Guan, Sheng; X. Guo, Xinbin
    Year: 2025

  • Title: Reconstructive Endovascular Treatment of Compensative-Flow–Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion
    Authors: T. Quan, Tao; X. Zhang, Xin; J. Li, Jinyi; C. Duan, Chuanzhi; S. Guan, Sheng
    Year: 2025

  • Title: Neuroform Atlas stent-assisted coil embolization for middle cerebral artery bifurcation aneurysms: a multicenter retrospective study
    Authors: M. Fan, Mengyan; J. Li, Jing; C. Duan, Chuanzhi; J. Zhang, Jiamei; S. Guan, Sheng
    Year: 2025

  • Title: A review of new advances in neuro-intervention
    Authors: X. Fu, Xiaojie; W. Gong, Wentao; S. Guan, Sheng
    Year: 2025

  • Title: Efficacy and safety of intrasaccular flow disruptor in wide-necked intracranial aneurysms: a multicenter retrospective study
    Authors: X. Zhang, Xiaowen; J. Li, Jing; X. Li, Xifeng; X. Zhang, Xin; S. Guan, Sheng
    Year: 2025
    Citations: 1

  • Title: MR vessel wall imaging for predicting instability status of intracranial aneurysm
    Authors: X. Ma, Xinmei; Q. Fu, Qichang; S. Xie, Shanshan; J. Cheng, Jingliang; S. Guan, Sheng
    Year: 2025

  • Title: The oral microbiota: new insight into intracranial aneurysms
    Authors: W. Gong, Wentao; H. Yu, Hairong; W. You, Wei; Y. Li, Youxiang; S. Guan, Sheng
    Year: 2025

  • Title: Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentation
    Authors: W. You, Wei; J. Feng, Junqiang; J. Lu, Jing; Y. Jiang, Yuhua; Y. Wang, Yan
    Year: 2024
    Citations: 4